287 related articles for article (PubMed ID: 11189233)
1. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
Shi Y; Tang D; Deng J; Su C
Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
[TBL] [Abstract][Full Text] [Related]
2. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
[TBL] [Abstract][Full Text] [Related]
3. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.
Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG
J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759
[TBL] [Abstract][Full Text] [Related]
5. Acromegaly in a family without a mutation in the menin gene.
Ackermann F; Krohn K; Windgassen M; Buchfelder M; Fahlbusch R; Paschke R
Exp Clin Endocrinol Diabetes; 1999; 107(1):93-6. PubMed ID: 10077364
[TBL] [Abstract][Full Text] [Related]
6. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients.
Yang I; Park S; Ryu M; Woo J; Kim S; Kim J; Kim Y; Choi Y
Eur J Endocrinol; 1996 Jun; 134(6):720-6. PubMed ID: 8766942
[TBL] [Abstract][Full Text] [Related]
8. Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly.
Hayward BE; Barlier A; Korbonits M; Grossman AB; Jacquet P; Enjalbert A; Bonthron DT
J Clin Invest; 2001 Mar; 107(6):R31-6. PubMed ID: 11254676
[TBL] [Abstract][Full Text] [Related]
9. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
[TBL] [Abstract][Full Text] [Related]
10. Does the prevalence of gsp mutations in GH-secreting pituitary adenomas differ geographically or racially? Prevalence of gsp mutations in Japanese patients revisited.
Yasufuku-Takano J; Takano K; Morita K; Takakura K; Teramoto A; Fujita T
Clin Endocrinol (Oxf); 2006 Jan; 64(1):91-6. PubMed ID: 16402935
[TBL] [Abstract][Full Text] [Related]
11. Gps mutations in Chilean patients harboring growth hormone-secreting pituitary tumors.
Johnson MC; Codner E; Eggers M; Mosso L; Rodriguez JA; Cassorla F
J Pediatr Endocrinol Metab; 1999; 12(3):381-7. PubMed ID: 10821217
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
Beuschlein F; Hancke K; Petrick M; Göbel H; Honegger J; Reincke M
Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
[TBL] [Abstract][Full Text] [Related]
13. Clinical correlates in acromegalic patients with pituitary tumors expressing GSP oncogenes.
Buchfelder M; Fahlbusch R; Merz T; Symowski H; Adams EF
Pituitary; 1999 May; 1(3-4):181-5. PubMed ID: 11081196
[TBL] [Abstract][Full Text] [Related]
14. Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas.
Barlier A; Gunz G; Zamora AJ; Morange-Ramos I; Figarella-Branger D; Dufour H; Enjalbert A; Jaquet P
J Clin Endocrinol Metab; 1998 May; 83(5):1604-10. PubMed ID: 9589663
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous gsp mutation renders ion channels of human somatotroph adenoma cells unresponsive to growth hormone-releasing hormone.
Yasufuku-Takano J; Takano K; Takei T; Fukumoto S; Teramoto A; Takakura K; Yamashita N; Fujita T
Endocrinology; 1999 May; 140(5):2018-26. PubMed ID: 10218950
[TBL] [Abstract][Full Text] [Related]
16. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and pathogenesis of pituitary adenomas.
Faglia G
Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():1-5. PubMed ID: 8396832
[TBL] [Abstract][Full Text] [Related]
18. GSPalpha mutations in Mexican patients with acromegaly: potential impact on long term prognosis.
Mendoza V; Sosa E; Espinosa-de-Los-Monteros AL; Salcedo M; Guinto G; Cheng S; Sandoval C; Mercado M
Growth Horm IGF Res; 2005 Feb; 15(1):28-32. PubMed ID: 15701569
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors.
Adams EF; Brockmeier S; Friedmann E; Roth M; Buchfelder M; Fahlbusch R
Neurosurgery; 1993 Aug; 33(2):198-203; discussion 203. PubMed ID: 8396223
[TBL] [Abstract][Full Text] [Related]
20. Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas.
Lania A; Persani L; Ballaré E; Mantovani S; Losa M; Spada A
J Clin Endocrinol Metab; 1998 May; 83(5):1624-8. PubMed ID: 9589667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]